Who backs Aviceda Therapeutics?
13 investors| Investor | Type |
|---|---|
| OrbiMed | Growth equity |
| Catalio Capital Management | Venture capital |
| Blue Owl Capital | — |
| Digitalis Ventures | Venture capital |
| Logos Capital | Hedge fund |
| Marshall Wace | Hedge fund |
| Omega Funds | PE / buyout |
| Longitude Capital | Venture capital |
| Aberdeen Investments (Scotland) | — |
| Enavate Sciences | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Aviceda Therapeutics investors
13 investors are on record for Aviceda Therapeutics, including OrbiMed, Catalio Capital Management, Blue Owl Capital and Digitalis Ventures. By type, the record holds 3 venture capital firms, 2 hedge funds and 1 private equity firm. The later-stage round in Nov 2024 drew 17 investors.
Free account
More of Aviceda Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Aviceda Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Aviceda Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View